## **Core Concept**
In a well-fed state, the body's primary goal is to store energy. Glucose-6-phosphate (G6P) is a key intermediate in glucose metabolism. The major fate of G6P depends on the tissue type and the body's metabolic state.

## **Why the Correct Answer is Right**
In a well-fed state, especially in the liver and muscles, the major fate of glucose-6-phosphate is **conversion to glycogen** (Option B). This process, known as glycogenesis, is crucial for storing glucose as glycogen, a complex carbohydrate that serves as a readily mobilizable storage form of glucose. The enzyme **glucose-6-phosphate dehydrogenase** and **glycogen synthase** play key roles in this pathway. Glycogen serves as a critical energy reserve that can be rapidly mobilized when needed.

## **Why Each Wrong Option is Incorrect**
- **Option A: Hydrolysis to glucose** - This is incorrect because in a well-fed state, the body aims to store energy, not release it. Hydrolysis to glucose would be more relevant in a fasting state or in specific tissues like the kidneys or intestines.
- **Option C: Isomerization to fructose 6 phosphate** - While this is a step in glycolysis, it is not the major fate of G6P in a well-fed state. Glycolysis is more relevant when the body needs to rapidly produce energy, such as in muscle contraction or in a fasting state.
- **Option D: Conversion to ribulose 5 phosphate** - This is part of the pentose phosphate pathway, which is important for nucleotide synthesis and generating NADPH. However, it is not the major fate of G6P in a well-fed state.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **glycogen storage diseases** result from defects in glycogenesis or glycogenolysis. These diseases highlight the importance of glycogen as an energy storage molecule. For example, von Gierke's disease (Type I glycogen storage disease) results from a deficiency in glucose-6-phosphatase, which affects both glycogenolysis and gluconeogenesis.

## **Correct Answer: B. Conversion to glycogen**